Violet Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $4.75M

  • Investors
  • 5

Violet Therapeutics General Information

Description

Developer of small molecule therapeutics designed to address neurodegenerative diseases of the central nervous system. The company leverages proprietary cell-to-cell interaction identification technology to discover novel drug targets, with its lead program focusing on receptor tyrosine kinase inhibition to modulate microglia-astrocyte interactions that drive glial dysfunction, enabling the pharmaceutical and biotechnology sectors to pursue new treatment approaches for conditions such as Alzheimer's and Parkinson's disease.

Contact Information

Website
www.violettx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 399 Revolution Drive
  • Somerville, MA 02145
  • United States
+1 (508)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 399 Revolution Drive
  • Somerville, MA 02145
  • United States
+1 (508)

Violet Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Violet Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 17-Apr-2026 $4.75M Completed Pre-Clinical Trials
1. Seed Round 20-Apr-2023 Completed Pre-Clinical Trials
To view Violet Therapeutics’s complete valuation and funding history, request access »

Violet Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-1
Seed
To view Violet Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Violet Therapeutics Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Violet Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025223542-A1 Imidazo-pyrazine derivatives and their use in the treatment of neurologic disorders Pending 16-Feb-2024
WO-2025175247-A1 Imidazo-pyrazine derivatives and their use in the treatment of neurologic disorders Pending 16-Feb-2024
WO-2025175088-A1 Imidazopyridine derivatives and methods of use Pending 16-Feb-2024 C07D471/04

Violet Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Violet Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
LifeSpan Vision Ventures Venture Capital Minority
Mass General Brigham Ventures Venture Capital Minority
Ono Venture Investment Corporate Venture Capital Minority
SV Health Investors PE/Buyout Minority
The University of Tokyo Edge Capital Venture Capital Minority
To view Violet Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Violet Therapeutics FAQs

  • When was Violet Therapeutics founded?

    Violet Therapeutics was founded in 2021.

  • Where is Violet Therapeutics headquartered?

    Violet Therapeutics is headquartered in Somerville, MA.

  • What is the size of Violet Therapeutics?

    Violet Therapeutics has 10 total employees.

  • What industry is Violet Therapeutics in?

    Violet Therapeutics’s primary industry is Drug Discovery.

  • Is Violet Therapeutics a private or public company?

    Violet Therapeutics is a Private company.

  • What is the current valuation of Violet Therapeutics?

    The current valuation of Violet Therapeutics is .

  • What is Violet Therapeutics’s current revenue?

    The current revenue for Violet Therapeutics is .

  • How much funding has Violet Therapeutics raised over time?

    Violet Therapeutics has raised $15.3M.

  • Who are Violet Therapeutics’s investors?

    LifeSpan Vision Ventures, Mass General Brigham Ventures, Ono Venture Investment, SV Health Investors, and The University of Tokyo Edge Capital have invested in Violet Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process